#192 - COVID Part 2: Masks, long COVID, boosters, mandates, treatments, and more

24 Jan 2022 · 170 min
Episode

24 Jan 2022 · 170 min

0:00

This is a group podcast discussion (recorded Jan 17, 2022) hosted by Peter Attia with guests Drs. Marty Makary, Zubin Damania, and Monica Gandhi reviewing updated data on Omicron and COVID-19 policy. Key points: early Omicron clinical series (Kaiser Southern California) showed large case counts with few ventilations and low hospitalization durations; substantial incidental-positive hospital admissions (50–67% reported at some centers); South African data and lab/animal studies suggest Omicron is intrinsically less virulent (~25% less than Delta) in addition to population immunity contributing to milder outcomes. Monica explains adaptive immunity: T cells provide durable cellular memory and B cells/antibodies (including mucosal IgA) provide variant-adaptive protection; natural infection + vaccination broadens neutralizing responses. Vaccine notes: Pfizer fully approved; Moderna EUA (as of discussion); adenoviral vector vaccines (J&J, AstraZeneca) produce stronger T cell responses but carry rare VITT risk; myocarditis risk higher with Moderna (dose effect), mitigated by spacing doses. Boosters raise antibodies but effects on transmission wane rapidly (~10 weeks per UK data); boosters should be targeted to those with clinical benefit. Masks: high-filtration masks (N95/KN95/KF94/FFP2) or well-sealed N95s provide best individual protection; cloth/surgical masks have limited population-level effect per reanalyses of RCTs; one-way masking for vulnerable individuals recommended. Long COVID: risk correlates with initial disease severity (~30% after severe disease), vaccination reduces risk of long COVID and may help treat it; incidence after mild breakthrough infections appears low. Therapeutics: most monoclonals lose activity against Omicron except sotrovimab; convalescent plasma (concentrated) and repurposed drugs (e.g., fluvoxamine) show signals but uptake/endorsement varied; antiviral availability (Paxlovid, Molnupiravir) discussed. Social/policy: debate over mandates, recognition of natural immunity (policy differences by country), school closures' harms, Sweden's alternative approach, and the social dynamics (tribalism, misinformation) that complicate public health messaging. Later segments dig into controversies around deplatformed figures (e.g., Robert Malone), the concept of 'mass formation psychosis' used to describe mainstream consensus, the ethics and practicality of vaccine mandates (including cases like Novak Djokovic), exit-strategy timing for mask/mandate rollbacks as Omicron wanes, and concerns about concentrated scientific authority and NIH funding influencing academic speech and research priorities.

Chapters

More from Darrian

Podcast11 Supplements Every 40+ Adult Should Consider
Podcast

11 Supplements Every 40+ Adult Should Consider

8mo ago
PodcastWhat MOST Doctors Get WRONG About Fixing Your Hormones
Podcast

What MOST Doctors Get WRONG About Fixing Your Hormones

8mo ago
PodcastThe NEW Food Pyramid and What is REALLY in our food
Podcast

The NEW Food Pyramid and What is REALLY in our food

8mo ago
PodcastTop 9 Root Causes of Inflammation (That Doctors Won’t Address)
Podcast

Top 9 Root Causes of Inflammation (That Doctors Won’t Address)

8mo ago
Podcast#381 ‒ Alzheimer's disease in women: how hormonal transitions impact the female brain, the role of HRT, genetics, and lifestyle on risk, and emerging diagnostics and therapies | Lisa Mosconi, Ph.D.
Podcast

#381 ‒ Alzheimer's disease in women: how hormonal transitions impact the female brain, the role of HRT, genetics, and lifestyle on risk, and emerging diagnostics and therapies | Lisa Mosconi, Ph.D.

8mo ago
Podcast3 EASY Skincare Swaps That Lower Toxins FAST (in 3 days!)
Podcast

3 EASY Skincare Swaps That Lower Toxins FAST (in 3 days!)

8mo ago
PodcastThe Medical Freedom War Is Here. Del Bigtree EXPOSES the Pharma Machine
Podcast

The Medical Freedom War Is Here. Del Bigtree EXPOSES the Pharma Machine

9mo ago
Podcast#380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats? | Layne Norton, Ph.D.
Podcast

#380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats? | Layne Norton, Ph.D.

9mo ago
Podcast3 Biggest Threat to Your Cellular Health That AGE YOU FASTER
Podcast

3 Biggest Threat to Your Cellular Health That AGE YOU FASTER

9mo ago
PodcastLisa Bevere: The Truth About Spiritual Attacks on Your Health (That the Church Isn’t Teaching)
Podcast

Lisa Bevere: The Truth About Spiritual Attacks on Your Health (That the Church Isn’t Teaching)

9mo ago
Podcast#379 - AMA #79: A guide to cardiorespiratory training at any fitness level to improve healthspan, lifespan, and long-term independence
Podcast

#379 - AMA #79: A guide to cardiorespiratory training at any fitness level to improve healthspan, lifespan, and long-term independence

9mo ago
See all content